Use of central nervous system drugs in combination with selective serotonin reuptake inhibitor treatment: A Bayesian screening study for risk of suicidal behavior is a research paper published in Frontiers in Psychiatry (2022). On theSindex it has a DataRank of 0.208. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Wellcome Trust
Grant: 202836/Z/16/Z
Wellcome Trust
Grant: 202836
Preventing violent crime and suicide in mental illness
National Institutes of Health
Grant: 5R00DA040727-04
Pharmacoepidemiologic Studies of Prescription Opioid Analgesic Risks
Swedish Research Council
Grant: unidentified
unidentified
National Institute on Drug Abuse
Vetenskapsrådet
American Foundation for Suicide Prevention
Wellcome Trust
Fields of Study
Keywords
Sustainable Development Goals